Novartis Institutes for BioMedical Research (NIBR)
PharmaceuticalsMassachusetts, United States5001-10000 Employees
Novartis Institutes for BioMedical Research (NIBR) is the biomedical research arm of Novartis, conducting discovery and translational science to advance medicines. The organization describes itself as having a large global team of scientists, physicians, and professionals working in an open, entrepreneurial, and collaborative culture. Its research covers a broad range of disease areas, including autoimmunity and inflammatory disease, cardiovascular and metabolic diseases, immuno-oncology, infectious diseases, musculoskeletal diseases, neuroscience, oncology, ophthalmology, and respiratory diseases. Its capabilities span scientific disciplines that combine laboratory work with computational approaches to apply discoveries across diseases sharing underlying mechanisms. NIBR operates from Cambridge, Massachusetts, and maintains additional locations in Basel, East Hanover, Emeryville, San Diego, and Shanghai, illustrating its multinational footprint within the pharmaceutical industry. The description frames NIBR as a central part of Novartis' efforts in translational research and drug discovery.
1-888-653-2347 
support@leadiq.com 
